TEVA
Live / Registered — Registered (as of 19 Dec 2023)
What this means for you
Registered since 19 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90266118
- Registration number
- 7249759
- Mark type
- Design + words
- Filed
- 20 Oct 2020
- Published for opposition
- 16 Mar 2021
- Registered
- 19 Dec 2023
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Owner
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
- Teva Pharmaceutical Industries Ltd., Jerusalem, IL
Prosecution history
- 19 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Nov 2023 — USE AMENDMENT FILED
- 08 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 02 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2023 — SOU EXTENSION 4 GRANTED
- 28 Apr 2023 — SOU EXTENSION 4 FILED
- 28 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2022 — SOU EXTENSION 3 GRANTED
- 02 Nov 2022 — SOU EXTENSION 3 FILED
- 02 Nov 2022 — SOU TEAS EXTENSION RECEIVED